跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FABHALTA iptacopan 200 mg hard capsules blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
FABHALTA iptacopan 200 mg hard capsules blister pack
Approved
STANDARD
FABHALTA iptacopan 200 mg hard capsules blister pack
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 31, 2025
Approval ID
58cbb4518c7f8ace
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
58cbb4518c7f8ace
Product Name
FABHALTA iptacopan 200 mg hard capsules blister pack
Artg Id
410830
Artg Name
FABHALTA iptacopan 200 mg hard capsules blister pack
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2024-08-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/cd2d8135aff6794ce7e463a603b3c6a5.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/9295f123a6324cf3b6be9ef2f95bd2ea.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 31, 2025
Approval ID
58cbb4518c7f8ace
Type
Standard
Back to TGA Approvals
